Revenue & profit both were less than expectations P/E=20 is not cheap CSR P/E=11 I am building shorts
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025